Preferred Label : maribavir;
MeSH note : has antiviral activity against HCMV; structure in first source;
CISMeF synonym : 1263W94; GW 257406X; 5,6-dichloro-2-isopropylamino-1-b-L-ribofuranosyl-1H-benzimidazole;
MeSH synonym : benzimidavir; 5,6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosylbenzimidazole;
MeSH hyponym : GW-1263; BW-1263W94; GW257406X; GW-257406X; 1263-W-94; GW 1263; BW 1263W94;
MeSH CAS label : 5,6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosylbenzimidazole;
Is substance : O;
UNII : PTB4X93HE1;
Origin ID : C400401;
UMLS CUI : C1508759;
ATC code(s)
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://ansm.sante.fr/tableau-acces-derogatoire/maribavir
2025
false
false
false
France
French
maribavir
drug information
administration, oral
maribavir
cytomegalovirus infections
adult
Refractory Cytomegalovirus Infection
antiviral agents
---
https://www.has-sante.fr/jcms/p_3417653/fr/livtencity-maribavir-infection-a-cmv
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
maribavir
cytomegalovirus infections
antiviral agents
Product containing only maribavir (medicinal product)
adult
organ transplantation
hematopoietic stem cell transplantation
Refractory Cytomegalovirus Infection
administration, oral
evaluation of the transparency committee
maribavir
---
https://www.ema.europa.eu/en/medicines/human/EPAR/livtencity
2023
false
false
false
Netherlands
French
English
drug approval
europe
treatment outcome
maribavir
maribavir
antiviral agents
antiviral agents
maribavir
syndication feed
summary of product characteristics
package leaflet
drug evaluation
orphan drug production
hematopoietic stem cell transplantation
organ transplantation
administration, oral
cytomegalovirus infections
adult
---
https://www.has-sante.fr/jcms/p_3419170/fr/livtencity-maribavir-cmv
2023
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
administration, oral
maribavir
Product containing only maribavir (medicinal product)
maribavir
antiviral agents
adult
cytomegalovirus infections
Refractory Cytomegalovirus Infection
transplantation
---